Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 17/20 | 0.70 |
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
| ▸ | ESRRG | P62508 | 1/20 | 0.45 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.45 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.43 |
| ▸ | RELA | Q04206 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9976495 | 0.92 | F10 (0.70) | F10ESRRG | |
| SCHEMBL9979769 | 0.90 | F10 (0.71) | F10LMNASMN1; SMN2 | |
| SCHEMBL9976455 | 0.82 | F10 (1.00) | F10NPC1RAB9A | |
| SCHEMBL9976504 | 0.81 | F10 (0.72) | F10 | |
| SCHEMBL9976498 | 0.79 | F10 (0.76) | F10NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL9979770 | 0.74 | F10 (0.76) | F10 | |
| SCHEMBL9928647 | 0.74 | F10 (0.84) | F10 | |
| SCHEMBL5399426 | 0.74 | F10 (1.00) | F10 | |
| SCHEMBL5409814 | 0.74 | F10 (0.84) | F10 | |
| SCHEMBL5406397 | 0.73 | F10 (0.83) | F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE43481-E1 | Diazepan derivatives or salts thereof | ASTELLAS PHARMA INC. (JP) | 2012-06-19 | — | — | US | disclosed |